Blasting prostate cancer with sound waves eliminates tumours

Researchers from the University of California at Los Angeles, who tested the technology on 115 men with prostate cancer, saw tumours destroyed in 80 per cent of men they treated.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Metabolic syndrome (MetS) can increase the risk of prostate cancer. Prostate-specific antigen (PSA) is the marker for prostate cancer puncture screening. The aim of our study was to investigate the association between MetS and its components with PSA levels. Data were obtained from 482 943 healthy men who underwent routine health check-ups from January 2010 to December 2017. We used linear regression analysis to evaluate the effects of MetS and its components on PSA levels. To explore the cumulative effect of MetS components, analysis of variance trend analysis was carried out. The PSA levels in the group with MetS were si...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Prostate Cancer Source Type: research
Preclinical studies have suggested the antitumorigenic properties of metformin on prostate cancer; results from epidemiological studies remain contradictory. We aim to investigate the evidence of metformin and the risk of prostate cancer. PubMed, Embase, Cochrane Library, and Web of Science databases were searched for eligible studies. Meta-analyses were carried out using the most fully adjusted hazard ratios and the corresponding 95% confidence intervals. Eighteen cohort studies and six case–control studies representing 2 009 504 male patients with type 2 diabetes mellitus were identified. The pooled HR of prostate ...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Prostate Cancer Source Type: research
Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): Kurmanov Talgat, Tassybaev Didar
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): David Nikoleishvilil, Givi Koberidze, Zaza Tchanturaia, Ambrosi Pertia
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): David Nikoleishvili, Givi Koberidze, Zaza Tchanturaia, Ambrosi Pertia
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): Besarion Partsvania, Alexandre Khuskivadze, Sopio Abazadze, Tamaz Sulaberidze, Ketevan Chubinidze
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: December 2019Source: European Urology Supplements, Volume 18, Issue 12Author(s): S.A. Reva, A.K. Nosov, M.V. Berkut, S.B. Petrov
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Purpose of review Despite increasing use of robotic surgery for radical prostatectomy, the benefit of robotic over open approach on different postoperative outcomes is still under debate. The present review aimed to provide a framework on the latest evidences on outcomes of prostate cancer (PCa) patients treated with robot-assisted radical prostatectomy (RARP) vs. open radical prostatectomy (ORP). Specifically, we focused on postoperative complications, urinary continence and erectile function recovery, PCa recurrence and PCa-related mortality. Recent findings Regarding perioperative outcomes, recent studies confirmed...
Source: Current Opinion in Urology - Category: Urology & Nephrology Tags: ROBOTIC SURGERY IN UROLOGY: FACTS AND REALITY: Edited by Firas Abdollah and Alexandre Mottrie Source Type: research
Purpose of review Local treatment of the primary by either radical prostatectomy or radiation therapy is discussed controversially. The role of cytoreductive radical prostatectomy has been evaluated in few retrospective clinical studies but data of prospective randomized clinical phase-III trials are lacking. It is the purpose of this review to reflect the current knowledge on indication, functional and oncological outcomes of cytoreductive radical prostatectomy to objectively highlight what can be expected from this approach. Recent findings Cytoreductive radical prostatectomy (cRP) is associated with a long overall ...
Source: Current Opinion in Urology - Category: Urology & Nephrology Tags: SPECIAL COMMENTARIES Source Type: research
Purpose of review In this review, we present an update on the safety and efficacy of prostate-specific membrane antigen (PSMA) radioligand therapy (PRLT) of metastatic castration-resistant prostate cancer (mCRPC). Recent findings Treatment of mCRPC with approved treatment agents leads to a survival advantage. The disease often progresses despite these treatments. PRLT with Lutetium-177 and Actinium-225 labeled with PSMA (LuPSMA and AcPSMA) have recently been shown to be effective and well tolerated for mCRPC treatment. LuPSMA is currently applied in patients who have exhausted approved treatment options or in whom the...
Source: Current Opinion in Urology - Category: Urology & Nephrology Tags: SPECIAL COMMENTARIES Source Type: research
More News: Cancer | Cancer & Oncology | Health | Prostate Cancer